A Pilot Study on the Role of Autoantibody Targeting the β1-Adrenergic Receptor in the Response to β-blocker Therapy for Congestive Heart Failure
To access this article, please choose from the options below
Conflict of interest: none.
PII: S1071-9164(08)01051-8
doi:10.1016/j.cardfail.2008.10.027
© 2009 Elsevier Inc. All rights reserved.
